⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809843 | 1.00 | — | — | |
| SCHEMBL5328004 | 0.89 | NOS3 (0.43) | — | |
| SCHEMBL503888 | 0.75 | — | — | |
| SCHEMBL30258630 | 0.74 | — | — | |
| SCHEMBL309925 | 0.74 | — | — | |
| SCHEMBL29361805 | 0.72 | — | — | |
| SCHEMBL31092839 | 0.72 | HDAC8 (0.45) | — | |
| SCHEMBL29249875 | 0.72 | HDAC8 (0.45) | — | |
| SCHEMBL1066257 | 0.72 | NOS3 (0.56) | — | |
| SCHEMBL88338 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 461 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111892553-A | Method for synthesizing ammonium acetate mediated benzothiazole compound | 衡阳师范学院 | 2020-11-06 | — | — | CN | claimed |
| CN-109776401-A | A method of preparing the chloro- 5- trifluoromethyl -2-aminopyridine of 6- | 成都博腾药业有限公司 | 2019-05-21 | — | — | CN | claimed |
| CN-109081840-A | A kind of preparation method of 5- bromo-7-azaindole | 郑州大学第附属医院 | 2018-12-25 | — | — | CN | claimed |
| JP-6009631-A | — | — | None | — | — | JP | disclosed |
| EP-4727647-A1 | GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF | The Broad Institute Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260103465-A1 | GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4720058-A2 | BIFUNCTIONAL DEGRADERS AND USES THEREOF | Casma Therapeutics, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260062443-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMA INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-12534453-B2 | Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof | MAZE THERAPEUTICS, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250325548-A1 | TUMOR SUPPRESSOR P73 TRANSCRIPTIONALLY REGULATES C-FLIP TO IMPEDE ITS PRIMING OF EXTRINSIC APOPTOSIS WHILE AN EXAMPLE SWITCHER COMPOUND CB-7587351 DEGRADES C-FLIP PROTEIN | UNIV BROWN (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4552697-A2 | PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE | Novartis AG (CH) | 2025-05-14 | — | — | EP | disclosed |
| WO-1999020624-A1 | BICYCLIC KINASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 1999-04-29 | — | — | WO | disclosed |
| WO-1998022457-A9 | ARYL AND HETEROARYL SUBSTITUTED FUSED PYRROLE ANTIINFLAMMATORY AGENTS | — | 1998-08-20 | — | — | WO | disclosed |
| WO-1998022457-A1 | ARYL AND HETEROARYL SUBSTITUTED FUSED PYRROLE ANTIINFLAMMATORY AGENTS | AMGEN INC. (US) | 1998-05-28 | — | — | WO | disclosed |
| JP-H069631-A | NEW PRODUCTION OF PYRAZOLOPYRIDINE | FUJISAWA PHARMACEUT CO LTD | 1994-01-18 | — | — | JP | disclosed |
| EP-0120589-B1 | IMIDAZO-HETEROCYCLIC COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-08 | — | — | EP | disclosed |
| US-4621084-A | CARDIOTONIC, ANTIULCER | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0120589-A1 | Imidazo-heterocyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-03 | — | — | EP | disclosed |
| US-4146642-A | ANTHELMINTICS | MERCK & CO., INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4105767-A | ANTHELMINTICS | MERCK & CO., INC. (US) | 1978-08-08 | — | — | US | disclosed |